Patents by Inventor Richard L. Gallo

Richard L. Gallo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240058395
    Abstract: This disclosure provides a synthesized version of S. felis C4 antimicrobial peptide as a topical antibiotic. S. felis C4 can be used as a probiotic strain of skin bacteria that can be transplanted onto the diseased skin of dogs, cats and dairy cows to outcompete and kill pathogenic bacteria that are causing infections such as bacterial pyoderma and mastitis.
    Type: Application
    Filed: January 26, 2021
    Publication date: February 22, 2024
    Inventors: Richard L. Gallo, Teruaki Nakatsuji, Kate Worthing, Alan O. O'Neill
  • Publication number: 20230181518
    Abstract: The disclosure demonstrates the role of mast cell stabilizers in treating rosacea. The disclosure also shows the role of mast cells, cathelicidin, serine protease and/or vitamin D3 in rosacea pathology and the use of antagonists and inhibitors thereof to treat rosacea.
    Type: Application
    Filed: June 7, 2022
    Publication date: June 15, 2023
    Inventors: Richard L. Gallo, Anna Di Nardo, Yumiko Muto
  • Publication number: 20230125917
    Abstract: The disclosure provides for novel antimicrobial agents, methods of making, and methods of use thereof.
    Type: Application
    Filed: June 8, 2022
    Publication date: April 27, 2023
    Inventors: Richard L. Gallo, Teruaki Nakatsuji
  • Publication number: 20230081146
    Abstract: The disclosure relates to compositions and methods for treating infection, allergic reactions, colitis, IBD, contact dermatitis, psoriasis, atopic dermatitis, graft vs. host disease and disorders and other disease and disorders comprising dendritic cell activation as well as compositions and method to improve allergen sensitization.
    Type: Application
    Filed: September 12, 2022
    Publication date: March 16, 2023
    Inventors: Richard L. Gallo, Tatsuya Dokoshi
  • Patent number: 11439659
    Abstract: The disclosure relates to compositions and methods for treating infection, allergic reactions, colitis, IBD, contact dermatitis, psoriasis, atopic dermatitis, graft vs. host disease and disorders and other disease and disorders comprising dendritic cell activation as well as compositions and method to improve allergen sensitization.
    Type: Grant
    Filed: December 3, 2019
    Date of Patent: September 13, 2022
    Assignee: The Regents of the University of California
    Inventors: Richard L. Gallo, Tatsuya Dokoshi
  • Publication number: 20220241288
    Abstract: The disclosure provides for methods and compositions useful for treating infections, cancer and neoplastic diseases and disorders.
    Type: Application
    Filed: January 18, 2022
    Publication date: August 4, 2022
    Inventors: Richard L. Gallo, Teruaki Nakatsuji
  • Patent number: 11400098
    Abstract: The disclosure provides for novel antimicrobial agents, methods of making, and methods of use thereof.
    Type: Grant
    Filed: December 20, 2019
    Date of Patent: August 2, 2022
    Assignee: The Regents of the University of California
    Inventors: Richard L. Gallo, Teruaki Nakatsuji
  • Patent number: 11382890
    Abstract: The disclosure demonstrates the role of mast cell stabilizers in treating rosacea. The disclosure also shows the role of mast cells, cathelicidin, serine protease and/or vitamin D3 in rosacea pathology and the use of antagonists and inhibitors thereof to treat rosacea.
    Type: Grant
    Filed: September 19, 2019
    Date of Patent: July 12, 2022
    Assignee: The Regents of the University of California
    Inventors: Richard L. Gallo, Anna Di Nardo, Yumiko Muto
  • Patent number: 11260058
    Abstract: The disclosure provides for compounds of the general structure: and methods of using and compositions comprising the compounds for treating infections, cancer and neoplastic diseases and disorders.
    Type: Grant
    Filed: March 27, 2018
    Date of Patent: March 1, 2022
    Assignee: The Regents of the University of California
    Inventors: Richard L. Gallo, Teruaki Nakatsuji
  • Publication number: 20210283215
    Abstract: The disclosure relates to composition and methods to treat dermatological diseases and disorders and to composition useful for treating acne.
    Type: Application
    Filed: September 13, 2019
    Publication date: September 16, 2021
    Inventors: Richard L. Gallo, Teruaki Nakatsuji, Alan O'Neill
  • Publication number: 20210228652
    Abstract: Methods and compositions comprising hogocidin peptides (SH-lantibiotics), derivatives and variants are provided. Also provided are methods and compositions comprising probiotic compositions utilizing strains of S. hominis and S. epidermidis that produce hogocidin, hogocidin-like peptides, or other inhibitors of skin pathogens. Methods of treatment for microbial skin infections and atopic dermatitis are also provided.
    Type: Application
    Filed: April 1, 2021
    Publication date: July 29, 2021
    Applicant: The Regents of the University of California
    Inventors: Teruaki Nakatsuji, Richard L. Gallo
  • Publication number: 20210177917
    Abstract: The disclosure relates to composition and methods to treat dermatological diseases and disorders and to composition that modulate skin barrier permeability.
    Type: Application
    Filed: August 31, 2018
    Publication date: June 17, 2021
    Inventors: Richard L. Gallo, Michael Williams
  • Patent number: 10980848
    Abstract: Methods and compositions comprising hogocidin peptides (SH-lantibiotics), derivatives and variants are provided. Also provided are methods and compositions comprising probiotic compositions utilizing strains of S. hominis and S. epidermidis that produce hogocidin, hogocidin-like peptides, or other inhibitors of skin pathogens. Methods of treatment for microbial skin infections and atopic dermatitis are also provided.
    Type: Grant
    Filed: October 15, 2019
    Date of Patent: April 20, 2021
    Assignee: The Regents of the University of California
    Inventors: Teruaki Nakatsuji, Richard L. Gallo
  • Publication number: 20200281935
    Abstract: The disclosure provides for novel antimicrobial agents, methods of making, and methods of use thereof.
    Type: Application
    Filed: December 20, 2019
    Publication date: September 10, 2020
    Inventors: Richard L. Gallo, Teruaki Nakatsuji
  • Publication number: 20200246397
    Abstract: Methods and compositions comprising hogocidin peptides (SH-lantibiotics), derivatives and variants are provided. Also provided are methods and compositions comprising probiotic compositions utilizing strains of S. hominis and S. epidermidis that produce hogocidin, hogocidin-like peptides, or other inhibitors of skin pathogens. Methods of treatment for microbial skin infections and atopic dermatitis are also provided.
    Type: Application
    Filed: October 15, 2019
    Publication date: August 6, 2020
    Applicant: The Regents of the University of California
    Inventors: Teruaki Nakatsuji, Richard L. Gallo
  • Publication number: 20200215023
    Abstract: The disclosure demonstrates the role of mast cell stabilizers in treating rosacea. The disclosure also shows the role of mast cells, cathelicidin, serine protease and/or vitamin D3 in rosacea pathology and the use of antagonists and inhibitors thereof to treat rosacea.
    Type: Application
    Filed: September 19, 2019
    Publication date: July 9, 2020
    Inventors: Richard L. Gallo, Anna Di Nardo, Yumiko Muto
  • Publication number: 20200188420
    Abstract: The disclosure relates to compositions and methods for treating infection, allergic reactions, colitis, IBD, contact dermatitis, psoriasis, atopic dermatitis, graft vs. host disease and disorders and other disease and disorders comprising dendritic cell activation as well as compositions and method to improve allergen sensitization.
    Type: Application
    Filed: December 3, 2019
    Publication date: June 18, 2020
    Inventors: Richard L. Gallo, Tatsuya Dokoshi
  • Publication number: 20200108073
    Abstract: The disclosure provides for methods and compositions useful for treating infections, cancer and neoplastic diseases and disorders.
    Type: Application
    Filed: March 27, 2018
    Publication date: April 9, 2020
    Inventors: Richard L. Gallo, Teruaki Nakatsuji
  • Publication number: 20190091232
    Abstract: The disclosure provides for novel antimicrobial agents, methods of making, and methods of use thereof.
    Type: Application
    Filed: September 25, 2018
    Publication date: March 28, 2019
    Inventors: Richard L. Gallo, Teruaki Nakatsuji
  • Publication number: 20180289751
    Abstract: Methods and compositions comprising hogocidin peptides (SH-lantibiotics), derivatives and variants are provided. Also provided are methods and compositions comprising probiotic compositions utilizing strains of S. hominis and S. epidermidis that produce hogocidin, hogocidin-like peptides, or other inhibitors of skin pathogens. Methods of treatment for microbial skin infections and atopic dermatitis are also provided.
    Type: Application
    Filed: May 5, 2016
    Publication date: October 11, 2018
    Inventors: Teruaki Nakatsuji, Richard L. Gallo